Teva Announces Launch of an authorized generic of Flector 1 Patch 1.3%
JERUSALEM — Teva Pharmaceutical Industries announced the launch of an authorized generic of Flector 1 Patch, 1.3%, in the U.S. Diclofenac epolamine topical patch, 1.3%, a non-steroidal anti-inflammatory drug (NSAID), is indicated for the topical treatment of acute pain due to minor strains, sprains and contusions. “The launch of our authorized generic of Flector Patch
